|
STX12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.557840E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.610600E-04 |
| Normal-vs-Stage2 |
7.217300E-04 |
| Normal-vs-Stage3 |
3.61770000000261E-05 |
| Normal-vs-Stage4 |
2.778800E-04 |
| Stage1-vs-Stage2 |
7.316000E-01 |
| Stage1-vs-Stage3 |
6.951800E-02 |
| Stage1-vs-Stage4 |
4.505600E-01 |
| Stage2-vs-Stage3 |
3.600000E-01 |
| Stage2-vs-Stage4 |
7.669400E-01 |
| Stage3-vs-Stage4 |
5.742600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.54319999999509E-05 |
| Normal-vs-AfricanAmerican |
7.618400E-02 |
| Normal-vs-Asian |
1.405720E-04 |
| Caucasian-vs-AfricanAmerican |
2.928400E-02 |
| Caucasian-vs-Asian |
7.129200E-01 |
| AfricanAmerican-vs-Asian |
4.525500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.562800E-04 |
| Normal-vs-Female |
1.167910E-04 |
| Male-vs-Female |
3.490600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.849600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.242220E-04 |
| Normal-vs-Age(61-80Yrs) |
9.75749999999609E-05 |
| Normal-vs-Age(81-100Yrs) |
3.700500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.741000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.044200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.534600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.946000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.848600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.542600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.510100E-02 |
| Classical-VS-Follicular |
6.219600E-01 |
| Classical-VS-Other |
7.416800E-01 |
| Classical-VS-Normal |
2.784300E-04 |
| Tall-VS-Follicular |
2.028000E-02 |
| Tall-VS-Other |
4.534400E-01 |
| Tall-VS-Normal |
1.65052999999693E-05 |
| Follicular-VS-Other |
9.067000E-01 |
| Follicular-VS-Normal |
8.597300E-04 |
| Other-VS-Normal |
2.017200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.8447000000017E-05 |
| Normal-vs-N1 |
2.520900E-03 |
| N0-vs-N1 |
4.769000E-01 |
|
|
